American Heart Journal

Papers
(The H4-Index of American Heart Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms153
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study152
Table of Contents89
Table of Contents81
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China72
Cardiac auscultation skills among medical trainees68
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF63
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study57
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial49
Editorial Board49
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes47
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network45
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network40
Information for Readers38
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function35
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e34
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER34
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging33
Information for Readers33
The trial to assess chelation therapy 2 (TACT2): Rationale and design33
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism33
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial33
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States32
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study32
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer32
Physician responses to apple watch-detected irregular rhythm alerts30
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial30
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial28
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study28
0.14018797874451